E Fund Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
E Fund Management's EW Position: Q2 2026 in Review
E Fund Management reduced its Edwards Lifesciences (EW) stake by 6% in Q2 2026, selling an estimated $28.9K and leaving 5,407 shares worth $489K. The position accounts for 0.01% of the portfolio, ranked #273.
E Fund Management first reported a position in EW in Q3 2021 and has held it in 16 quarters since. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- E Fund Management held 5,407 shares of Edwards Lifesciences worth $489K as of Q2 2026.
- E Fund Management sold 345 Edwards Lifesciences shares in Q2 2026, an estimated $28.9K.
- Edwards Lifesciences made up 0.01% of E Fund Management's portfolio in Q2 2026, its #273 holding.
- E Fund Management first reported a position in Edwards Lifesciences in Q3 2021 and has held it in 16 quarters since.
- 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.